Lynch syndrome: Acetylsalicylic acid reduces colorectal cancer rates by around 60%
The CAPP2 ( Colorectal Adenoma/carcinoma Prevention Programme ) trial has shown a reduction in colorectal cancer incidence of over 60% in patients at genetically increased risk who use Acetylsalicylic ...
read article